Výsledky vyhledávání

Akademický článek

Self-reported sexual health: Breast cancer survivors compared to women from the general population – an observational study

Autor: Anne Oberguggenberger, Caroline Martini, Nathalie Huber, Lesley Fallowfield, Michael Hubalek, Martin Daniaux, Barbara Sperner-Unterweger, Bernhard Holzner, Monika Sztankay, Eva Gamper, Verena Meraner

Publikováno v: BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)

Abstract Background Cancer survivorship is of increasing importance in post-treatment care. Sexual health (SH) and femininity can be crucial issues for women surviving cancer. We aimed to determine a more complete understanding of the contribution th

Externí odkaz: https://doaj.org/article/0988773794ac491b87935d13939d6698

Zobrazit plný text záznamu

The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L

Autor: Madeleine King, Fabio Efficace, Reinhard Stauder, Richard Norman, Pasquale Niscola, Eva Gamper, Jo Caers, Massimo Breccia, Giovanni Caocci, Kathrin Sommer, Andrea Patriarca, Giuseppe A. Palumbo, Uwe Platzbecker, Marco Vignetti, Francesco Cottone

Publikováno v: Journal of Clinical Epidemiology. 137:31-44

Background The aim was to investigate the relative validity of the preference-based measure EORTC QLU-C10D in comparison with the EQ-5D-3L in myelodysplastic syndromes (MDS) patients. Methods We used data from an international multicentre, observatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0566009b40947a96e157887f0cf7bec9
https://doi.org/10.1016/j.jclinepi.2021.03.015

Zobrazit plný text záznamu

Estimation of an EORTC QLU-C10 Value Set for Spain Using a Discrete Choice Experiment

Autor: Madeleine King, Georg Kemmler, Rosalie Viney, Aureliano Paolo Finch, Eva Gamper, Richard Norman, Bernhard Holzner

Publikováno v: Pharmacoeconomics

Background The EORTC QLU-C10D is a preference-based measure derived from the EORTC QLQ-C30. For use in economic evaluations, country-specific value sets are needed. This study aimed to generate an EORTC QLU-C10 value set for Spain. Methods A sample o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5be92d760a65a32719aefbca95319c86
https://doi.org/10.1007/s40273-021-01058-x

Zobrazit plný text záznamu

Dutch utility weights for the EORTC cancer-specific utility instrument

Autor: Femke Jansen, Madeleine King, Eva Gamper, Irma M. Verdonck-de Leeuw, Georg Kemmler, Bernhard Holzner, Richard Norman

Publikováno v: Quality of Life Research, 30(7), 2009-2019. Springer Netherlands
the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group 2021, ' Dutch utility weights for the EORTC cancer-specific utility instrument : the Dutch EORTC QLU-C10D ', Quality of Life Research, vol. 30, no. 7, pp. 2009-2019 . https://doi.org/10.1007/s11136-021-02767-8
Quality of Life Research
Verdonck-de Leeuw, I M, Gamper, E, Norman, R, Holzner, B, King, M, Kemmler, G & on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group 2021, ' Dutch utility weights for the EORTC cancer-specific utility instrument : the Dutch EORTC QLU-C10D ', Quality of Life Research, vol. 30, no. 7, pp. 2009-2019 . https://doi.org/10.1007/s11136-021-02767-8

Purpose To measure utilities among cancer patients, a cancer-specific utility instrument called the European Organization for Research and Treatment of Cancer (EORTC) QLU-C10D has been developed based on EORTC quality of life core module (QLQ-C30). T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99389326f0a2500fc9a6cee51485e945
https://doi.org/10.1007/s11136-021-02767-8

Zobrazit plný text záznamu

Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module)

Autor: John K, Ramage, Elizabeth, Friend, Jordan, Randell, Barbara, King, Paz, Fernandez Ortega, Mairéad G, McNamara, Gregory, Kaltsas, Massimo, Falconi, Jaroslav, Cwikla, Jaume, Capdevila, Simona, Grozinsky-Glasberg, Dalvinder, Mandair, Eva, Gamper, Raj, Srirajaskanthan, Martin, O Weickert, Debra, Gray

Publikováno v: Scientia
Dipòsit Digital de la UB
Universidad de Barcelona
Ramage, J K, Friend, E, Randell, J, King, B, Fernandez Ortega, P, Mcnamara, M G, Kaltsas, G, Falconi, M, Cwikla, J, Capdevila, J, Grozinsky-glasberg, S, Mandair, D, Gamper, E, Srirajaskanthan, R, Weickert, M & Gray, D 2022, ' Development of a Quality of Life Questionnaire for Patients with Pancreatic Neuroendocrine Tumours (the PANNET module) ', Journal of Neuroendocrinology . https://doi.org/10.1111/jne.13097

Gastrinoma; Insulinoma; Pancreatic neuroendocrine tumour Gastrinoma; Insulinoma; Tumor neuroendocrino pancreático Gastrinoma; Insulinoma; Tumor neuroendocrí pancreàtic Pancreatic neuroendocrine tumours (panNET) are heterogeneous neoplasms usually

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::415b651467514a6e5ee249610cd23868
https://hdl.handle.net/11351/7842

Zobrazit plný text záznamu

Evaluating cost-effectiveness in the management of neuroendocrine neoplasms

Autor: Rajaventhan Srirajaskanthan, Tristan Snowsill, John Ramage, Ruben Mujica-Mota, BE White, Eva Gamper

Publikováno v: Reviews in Endocrine & Metabolic Disorders

The rapid evolution of novel, costly therapies for neuroendocrine neoplasia (NEN) warrants formal high-quality cost-effectiveness evaluation. Costs of individual investigations and therapies are high; and examples are presented. We aimed to review th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78aecdaae746391648c2a5843a3b641c
https://doi.org/10.1007/s11154-020-09608-y

Zobrazit plný text záznamu

Autor: Benjamin E White, Simona Grozinsky-Glasberg, Eva Gamper, Rajaventhan Srirajaskanthan, Maralyn Druce, Debra Gray, Ruben Mujica-Mota, John Ramage

Publikováno v: Endocrine-Related Cancer. 27:R267-R280

Incidence of neuroendocrine neoplasia (NEN) is increasing, as is use of health-related quality of life (HRQoL) measurement in clinical trials. Following development of validated questionnaires, HRQoL is widely used to assess outcomes. This review is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89a86e9b6b4e44498ff639d8edeaf0d8
https://doi.org/10.1530/erc-20-0066

Zobrazit plný text záznamu

EORTC QLU-C10D value sets for Austria, Italy, and Poland

Autor: Francesco Cottone, Georg Kemmler, Richard Norman, Bernhard Holzner, Madeleine King, F. Efficace, Eva Gamper

Publikováno v: Quality of Life Research

Objective To develop Austrian, Italian, and Polish general population value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30, and to descriptively compare their index scores for distinct health states. Meth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4b1a7c313d4ea515ea33bdb9e752531
https://doi.org/10.1007/s11136-020-02536-z

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vyhledávací nástroje:

Upřesnit hledání